Search

Your search keyword '"Aigret, Benoit"' showing total 14 results

Search Constraints

Start Over You searched for: Author "Aigret, Benoit" Remove constraint Author: "Aigret, Benoit"
14 results on '"Aigret, Benoit"'

Search Results

2. Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial

3. Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study

4. Barrett’s oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux

6. High-dose oral vitamin D supplementation and mortality in people aged 65 - 84 years: the VIDAL cluster feasibility RCT of open versus double-blind individual randomisation

7. Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial

8. 634 RESULTS FROM THE BARRETT'S OESOPHAGUS TRIAL 3 (BEST3): A RANDOMISED CONTROLLED TRIAL COMPARING THE CYTOSPONGE™-TFF3 TEST WITH USUAL CARE TO IDENTIFY OESOPHAGEAL PRECANCER IN PRIMARY CARE PATIENTS WITH CHRONIC GASTROESOPHAGEAL REFLUX

9. Evaluation of a minimally invasive cell sampling device coupled with assessment of Trefoil Factor 3 expression for diagnosing Barrett's esophagus: a multi-center case--control study

10. Sa1643 - Feasibility of the Implementation of Cytosponge as a Triage Test for Reflux Symptoms in Primary Care: Barrett's Esophagus Screening Trial 3 (Best3)

11. Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): A double-blind, randomised controlled trial

13. Asymmetric Synthesis of 1-Aza-4-deoxypicropodophyllotoxin.

14. High-dose oral vitamin D supplementation and mortality in people aged 65-84 years: the VIDAL cluster feasibility RCT of open versus double-blind individual randomisation.

Catalog

Books, media, physical & digital resources